Skip to content

Clinical trials

Phase 3 Agnosia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Agnosia Phase: Phase 3 Clear all

205 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20045
20053
200611
20077
20086
20094
20103
20119
201215
20135
20146
201511
201611
201710
20185
20196
20205
202121
202215
202314
20249
20259
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed104
Unknown status40
Terminated20
Recruiting19
Withdrawn9
Not yet recruiting6
Active, not recruiting4
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Apurano Pharmaceuticals GmbH8
University of Toronto6
Ain Shams University5
Baudax Bio5
Pacira Pharmaceuticals, Inc5
Stanford University4
University Hospital, Bordeaux4
Avenue Therapeutics, Inc.3
Emory University3
Hadassah Medical Organization3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Agnosia205
Pain53
Postoperative Pain46
Chronic Pain11
Marijuana Abuse8
Somatoform Disorders8
Neuralgia6
Acute Pain4
Anemia, Sickle Cell4
Breast Neoplasms4

Trials

Showing 76 to 100 of 205. Each trial links to its page on Pharma Observatory.

105 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.